Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

INTRODUCTION: Inadequate initial treatment and delayed hemodynamic stabilization (HDS) may be associated with increased risk of death in severe sepsis patients. METHODS: In order to compare the hemodynamic efficacy and safety of 6% HES 130/0.4 and NaCl 0.9% for HDS in patients with severe sepsis, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Guidet, Bertrand, Martinet, Olivier, Boulain, Thierry, Philippart, Francois, Poussel, Jean François, Maizel, Julien, Forceville, Xavier, Feissel, Marc, Hasselmann, Michel, Heininger, Alexandra, Van Aken, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580640/
https://www.ncbi.nlm.nih.gov/pubmed/22624531
http://dx.doi.org/10.1186/cc11358

Ejemplares similares

Ejemplares similares